Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting a growth of 16%. Consolidated Net Profit of ₹1,984 Crore, up 187% from -(₹2,227) Crore in the same quarter of the previous year. The Earnings per Share is ₹8.3, up 187% from -(₹9.49) in the same quarter of the previous year.
Sun Pharmaceuticals Ltd Q4FY23 results out, revenue grows by 16%
Related Post
- Firstsource Solutions Q2 FY26 Earnings Results
Firstsource Solutions Ltd, a leading player in Business Process Management (BPM) and part of the…
-
Foseco India Q2 FY26 Earnings Results
Foseco India Ltd, incorporated in 1958 and engaged in manufacturing metallurgical additives and consumables that…
-
Force Motors Q2 FY26 Earnings Results
Force Motors Ltd, founded in 1958 and part of the Abhay Firodia Group, specializes in…